المؤلفون: Petersen, Astrid Heide, Kohler, G, Korsatko, S, Wutte, A, Wonisch, M, Jeppesen, OK, Sparre, T, Clauson, Per, Laursen, Torben, Wollmer, Per, Pieber, Thomas R

المصدر: Petersen, A H, Kohler, G, Korsatko, S, Wutte, A, Wonisch, M, Jeppesen, OK, Sparre, T, Clauson, P, Laursen, T, Wollmer, P & Pieber, T R 2007, ' The effect of exercise on the absorption of inhaled human insulin via the AERx(R) iDMS in people with type 1 diabetes ', Diabetes Care, vol. 30, no. 10, pp. 2571-2576 .

مصطلحات موضوعية: Diabetes, Insulin, Lung, Administration, Inhalation, Absorption, Pharmacokinetics

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pure_au_____::a70bef5ba04c1398952112ac0489d5e3
https://pure.au.dk/portal/da/publications/the-effect-of-exercise-on-the-absorption-of-inhaled-human-insulin-via-the-aerxr-idms-in-people-with-type-1-diabetes(b1dbca90-83ab-11dc-bee9-02004c4f4f50).html

المؤلفون: Kesecioglu J, Beale R, Stewart TE, Findlay GP, Rouby JJ, Holzapfel L, Bruins P, Steenken EJ, Jeppesen OK, Lachmann B

المصدر: American Journal of Respiratory & Critical Care Medicine; Nov2009, Vol. 180 Issue 10, p989-994, 6p

المؤلفون: Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Deanfield J; Institute of Cardiovascular Science, University College London, London, U.K., Kahn SE; VA Puget Sound Health Care System and University of Washington, Seattle, WA., Weeke PE; Novo Nordisk A/S, Søborg, Denmark., Toplak H; Division of Endocrinology and Diabetology, Department of Medicine, Medical University of Graz, Graz, Austria., Scirica BM; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Rydén L; Department of Medicine K2, Karolinska Institute, Stockholm, Sweden., Rathor N; Novo Nordisk A/S, Søborg, Denmark., Plutzky J; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Morales C; Vithas Hospital, Sevilla, Spain., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH., Lehrke M; University of Aachen, Aachen, Germany., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Gajos G; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, U.K., Cariou B; L'institut du thorax, INSERM, CNRS, CHU Nantes, Nantes Université, Nantes, France., Ryan D; Pennington Biomedical Research Center, Baton Rouge, LA.

مؤلفون مشاركون: SELECT Trial Investigators

المصدر: Diabetes care [Diabetes Care] 2024 Aug 01; Vol. 47 (8), pp. 1360-1369.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Glycated Hemoglobin*/metabolism , Obesity*/complications , Obesity*/drug therapy , Overweight*/complications , Overweight*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Cardiovascular Diseases/prevention & control ; Cardiovascular Diseases/mortality ; Hypoglycemic Agents/therapeutic use

المؤلفون: Kahn SE; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle., Deanfield JE; Institute of Cardiovascular Science, University College London, London, U.K., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Emerson SS; Department of Biostatistics, University of Washington, Seattle, WA., Boesgaard TW; Novo Nordisk A/S, Søborg, Denmark., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, U.K., Kushner RF; Department of Medicine, Northwestern University Feinberg School of Medicine, Northwestern University, Chicago, IL., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX., Burguera B; Endocrinology & Metabolism Institute, Cleveland Clinic, Cleveland, OH., Gajos G; Department of Coronary Artery Disease and Heart Failure, Jagiellonian University Medical College, Kraków, Poland., Horn DB; Department of Surgery, John P. and Katherine G. McGovern Medical School, University of Texas, Houston, TX., Hramiak IM; Western University, London, Ontario, Canada., Jastreboff AM; Endocrinology and Metabolism, Department of Medicine, and Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT., Kokkinos A; First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece., Maeng M; Department of Cardiology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Tinahones FJ; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), CIBERobn, and Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Malaga University, Málaga, Spain., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH., Ryan DH; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle.; Pennington Biomedical Research Center, Baton Rouge, LA.

مؤلفون مشاركون: SELECT Trial Investigators

المصدر: Diabetes care [Diabetes Care] 2024 Aug 01; Vol. 47 (8), pp. 1350-1359.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Overweight*/drug therapy , Overweight*/complications , Obesity*/drug therapy , Obesity*/complications , Blood Glucose*/drug effects , Blood Glucose*/metabolism , Glycated Hemoglobin*/metabolism, Humans ; Male ; Middle Aged ; Female ; Aged ; Double-Blind Method ; Hypoglycemic Agents/therapeutic use

المؤلفون: Ryan DH; Pennington Biomedical Research Center, Baton Rouge, LA, USA. ryandh@pbrc.edu., Lingvay I; Department of Internal Medicine/Endocrinology and Peter O' Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA., Deanfield J; Institute of Cardiovascular Science, University College London, London, UK., Kahn SE; VA Puget Sound Health Care System and University of Washington, Seattle, WA, USA., Barros E; Novo Nordisk A/S, Søborg, Denmark., Burguera B; Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH, USA., Colhoun HM; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Cercato C; Obesity Unit, Department of Endocrinology, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil., Dicker D; Internal Medicine Department D, Hasharon Hospital-Rabin Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Horn DB; Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston, TX, USA., Hovingh GK; Novo Nordisk A/S, Søborg, Denmark., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Kokkinos A; First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic, and Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Meyhöfer SM; Institute of Endocrinology & Diabetes, University of Lübeck, Lübeck, Germany., Oral TK; Novo Nordisk A/S, Søborg, Denmark., Plutzky J; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., van Beek AP; University of Groningen, University Medical Center Groningen, Department of Endocrinology, Groningen, the Netherlands., Wilding JPH; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK., Kushner RF; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

المصدر: Nature medicine [Nat Med] 2024 Jul; Vol. 30 (7), pp. 2049-2057. Date of Electronic Publication: 2024 May 13.

نوع المنشور: Journal Article; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects , Weight Loss*/drug effects , Obesity*/drug therapy , Obesity*/complications , Body Mass Index*, Humans ; Male ; Female ; Middle Aged ; Adult ; Aged ; Treatment Outcome ; Double-Blind Method ; Cardiovascular Diseases/prevention & control

المؤلفون: Kolotkin RL; Quality of Life Consulting, Durham, North Carolina, USA.; Family Medicine and Community Health, Duke University School of Medicine, Durham, North Carolina, USA.; Centre of Health Research, Helse Førde Hospital Trust, Førde, Norway.; Morbid Obesity Centre, Vestfold Hospital Trust, Tønsberg, Norway., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Baker-Knight J; Novo Nordisk A/S, Søborg, Denmark., Lee SY; Family Medicine Clinic and Biomedical Research Institute, Pusan National University Yangsan Hospital, Yangsan-si, Gyeongsangnam-do, South Korea.; Department of Medical Education, Pusan National University School of Medicine, Yangsan-si, Gyeongsangnam-do, South Korea., Tokita A; Novo Nordisk Pharma Ltd, Chiyoda-ku, Tokyo, Japan., Kadowaki T; Toranomon Hospital, Minato City, Japan.

المصدر: Clinical obesity [Clin Obes] 2023 Aug; Vol. 13 (4), pp. e12589. Date of Electronic Publication: 2023 Mar 11.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101560587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-8111 (Electronic) Linking ISSN: 17588103 NLM ISO Abbreviation: Clin Obes Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Diabetes Mellitus, Type 2*, Adult ; Humans ; East Asian People ; Obesity/psychology ; Patient Reported Outcome Measures

المؤلفون: Weghuber D; Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria., Boberg K; Novo Nordisk A/S, Søborg, Denmark., Hesse D; Novo Nordisk A/S, Søborg, Denmark., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Sørrig R; Novo Nordisk A/S, Søborg, Denmark., Kelly AS; Department of Pediatrics & Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, MN, USA.

مؤلفون مشاركون: STEP TEENS Investigators

المصدر: Journal of comparative effectiveness research [J Comp Eff Res] 2023 Feb; Vol. 12 (2), pp. e220187. Date of Electronic Publication: 2022 Dec 19.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Becaris Publishing Country of Publication: England NLM ID: 101577308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6313 (Electronic) Linking ISSN: 20426305 NLM ISO Abbreviation: J Comp Eff Res Subsets: MEDLINE

مواضيع طبية MeSH: Obesity*/drug therapy , Glucagon-Like Peptides*/adverse effects , Glucagon-Like Peptides*/pharmacology, Adolescent ; Humans ; Weight Loss/drug effects ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Body Mass Index

المؤلفون: Weghuber D; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Barrett T; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Barrientos-Pérez M; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Gies I; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Hesse D; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Jeppesen OK; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Kelly AS; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Mastrandrea LD; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Sørrig R; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.)., Arslanian S; From the Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria (D.W.); the Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom (T.B.); the Division of Pediatric Endocrinology, Hospital Ángeles Puebla, Puebla City, Mexico (M.B.-P.); the Department of Pediatrics, Division of Pediatric Endocrinology, Universitair Ziekenhuis Brussel, Brussels (I.G.); Novo Nordisk, Søborg, Denmark (D.H., O.K.J., R.S.); the Department of Pediatrics and the Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis (A.S.K.); the Division of Pediatric Endocrinology and Diabetes, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY (L.D.M.); and the Center for Pediatric Research in Obesity and Metabolism, Division of Pediatric Endocrinology, Diabetes, and Metabolism, University of Pittsburgh School of Medicine, and UPMC Children's Hospital of Pittsburgh, Pittsburgh (S.A.).

مؤلفون مشاركون: STEP TEENS Investigators

المصدر: The New England journal of medicine [N Engl J Med] 2022 Dec 15; Vol. 387 (24), pp. 2245-2257. Date of Electronic Publication: 2022 Nov 02.

نوع المنشور: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

مواضيع طبية MeSH: Pediatric Obesity*/drug therapy , Pediatric Obesity*/therapy , Anti-Obesity Agents*/administration & dosage , Anti-Obesity Agents*/adverse effects, Adolescent ; Humans ; Double-Blind Method ; Weight Loss/drug effects ; Healthy Lifestyle ; Glucagon-Like Peptide-1 Receptor/agonists ; Body Mass Index ; Administration, Cutaneous ; Child

المؤلفون: Davies M; Diabetes Research Centre, University of Leicester, Leicester, UK; NIHR Leicester Biomedical Research Centre, Leicester, UK., Færch L; Novo Nordisk, Søborg, Denmark., Jeppesen OK; Novo Nordisk, Søborg, Denmark., Pakseresht A; Novo Nordisk, Søborg, Denmark., Pedersen SD; C-ENDO Diabetes and Endocrinology Clinic Calgary, Calgary, AB, Canada., Perreault L; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX, USA., Shimomura I; Graduate School of Medicine, Osaka University, Suita, Osaka, Japan., Viljoen A; Borthwick Diabetes Research Unit, Lister Hospital, Stevenage, UK., Wadden TA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lingvay I; University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: ildiko.lingvay@utsouthwestern.edu.

مؤلفون مشاركون: STEP 2 Study Group

المصدر: Lancet (London, England) [Lancet] 2021 Mar 13; Vol. 397 (10278), pp. 971-984. Date of Electronic Publication: 2021 Mar 02.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

مواضيع طبية MeSH: Glucagon-Like Peptides/*therapeutic use , Obesity/*drug therapy , Weight Loss/*drug effects, Adult ; Aged ; Diabetes Mellitus, Type 2/drug therapy ; Double-Blind Method ; Female ; Glucagon-Like Peptides/administration & dosage ; Glucagon-Like Peptides/adverse effects ; Glycated Hemoglobin/analysis ; Humans ; Hypoglycemic Agents/administration & dosage ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Injections, Subcutaneous ; Male ; Middle Aged ; Overweight/drug therapy ; Treatment Outcome

المؤلفون: Husain M; Ted Rogers Centre for Heart Research, Toronto General Hospital Research Institute, Toronto, Canada., Bain SC; Swansea University Medical School, Diabetes Research Unit Cymru, Swansea, UK., Jeppesen OK; Novo Nordisk A/S, Søborg, Denmark., Lingvay I; UT Southwestern Medical Center, Internal Medicine and Population and Data Sciences, Dallas, Texas., Sørrig R; Novo Nordisk A/S, Søborg, Denmark., Treppendahl MB; Novo Nordisk A/S, Søborg, Denmark., Vilsbøll T; Steno Diabetes Center Copenhagen, Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2020 Mar; Vol. 22 (3), pp. 442-451. Date of Electronic Publication: 2020 Feb 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Cardiovascular Diseases*/epidemiology , Cardiovascular Diseases*/prevention & control , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy, Glucagon-Like Peptides/therapeutic use ; Heart Disease Risk Factors ; Humans ; Hypoglycemic Agents/therapeutic use ; Risk Factors